Newsfeeds - Spark Newswire

2 minute read

Why Did Novavax Stock Get Slammed Today?

Today, 10:15 PM

Novavax, Inc. (NASDAQ: NVAX) shares tumbled lower Wednesday after retail traders were able to push the stock lower. Vaccine stocks were very volatile today, and many are trading lower amid possible profit-taking as there are COVID-19 delta variant concerns.

NVAX

1 minute read

Trading Ideas

Novavax Key Daily Technical Levels

By Benzinga Newsdesk

Today, 10:15 PM

YTD Support: $117.50 YTD Resistance: $331 Swing Support: $170 Swing Resistance: $229 * We’re looking for feedback on this kind of content! Is this content helpful? Anything to

NVAX

2 minute read

Understanding Novavax’s Unusual Options Activity

By Benzinga Insights

Today, 10:15 PM

Shares of Novavax (NASDAQ:NVAX) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $191.32.

NVAX

4 minute read

42 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 10:15 PM

Gainers Newegg Commerce, Inc. (NASDAQ: NEGG) jumped 79% to $48.70 after jumping around 42% on Tuesday.

AMST

1 minute read

South Korea Negotiating With mRNA COVID-19 Vaccine Makers To Produce Up To 1B Doses: Reuters

By Vandana Singh

Today, 10:15 PM

South Korea is reportedly in talks with mRNA vaccine makers, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), to produce COVID-19 shots in the country.

AZN

3 minute read

News

Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine

By Michael Horton

Today, 10:15 PM

Novavax, Inc. (NASDAQ:NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the publication of results from the final analysis of a pivotal Phase 3 clinical

NVAX

2 minute read

UK Study Of COVID-19 Shots Mix-Match Shows Immune Response, Can Add Flexibility To Vaccination Programs: CNBC

By Vandana Singh

Today, 10:15 PM

Mixing and matching the coronavirus vaccines made by Pfizer Inc (NYSE:PFE) – BioNTech SE (NASDAQ:BNTX) and AstraZeneca Plc (NASDAQ:AZN) – Oxford showed a “robust”…

AZN

1 minute read

News

Return On Capital Employed Overview: Novavax

By Benzinga Insights

Today, 10:15 PM

During Q1, Novavax's (NASDAQ:NVAX) reported sales totaled $447.23 million. Despite a 14.1% in earnings, the company posted a loss of $208.63 million. In Q4, Novavax brought in $276.66 million in sales but lost $182.85 million in earnings.

NVAX

2 minute read

Jim Cramer Says Moderna ‘Excellent Company And Stock’ With Reach Beyond COVID-19

By Madhukumar Warrier

Today, 10:15 PM

CNBC host Jim Cramer believes biotechnology company Moderna Inc. (NASDAQ: MRNA) is an “excellent company and stock” that has a reach far beyond COVID-19. What Happened: Cramer made the comments on Twitter.

BNTX

6 minute read

14 Biotech Stocks To Watch Over The Next 6 Months

By Shanthi Rexaline

Today, 10:15 PM

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks.

AERI